These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34292959)

  • 21. A comparative study of thulium laser resection of the prostate and bipolar transurethral plasmakinetic prostatectomy for treating benign prostatic hyperplasia.
    Peng B; Wang GC; Zheng JH; Xia SQ; Geng J; Che JP; Yan Y; Huang JH; Xu YF; Yang B
    BJU Int; 2013 Apr; 111(4):633-7. PubMed ID: 23107074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Economic Value of the Transurethral Resection in Saline System for Treatment of Benign Prostatic Hyperplasia in England and Wales: Systematic Review, Meta-analysis, and Cost-Consequence Model.
    Treharne C; Crowe L; Booth D; Ihara Z
    Eur Urol Focus; 2018 Mar; 4(2):270-279. PubMed ID: 28753756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population based comparative effectiveness of transurethral resection of the prostate and laser therapy for benign prostatic hyperplasia.
    Strope SA; Yang L; Nepple KG; Andriole GL; Owens PL
    J Urol; 2012 Apr; 187(4):1341-5. PubMed ID: 22341267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Transurethral resection of the prostate in the treatment of benign prostatic hyperplasia].
    Bardos A; Hornak M; Novotny V
    Bratisl Lek Listy; 2001; 102(2):79-83. PubMed ID: 11396128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term follow-up after transurethral resection of the prostate, contact laser prostatectomy, and electrovaporization.
    van Melick HH; van Venrooij GE; Boon TA
    Urology; 2003 Dec; 62(6):1029-34. PubMed ID: 14665349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends and Perioperative Outcomes Across Major Benign Prostatic Hyperplasia Procedures from the ACS-NSQIP 2011-2015.
    Anderson BB; Heiman J; Large T; Lingeman J; Krambeck A
    J Endourol; 2019 Jan; 33(1):62-68. PubMed ID: 30039715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prostate cancer after prostatectomy for benign prostatic hyperplasia].
    Hua L; Zhang J; Wu H; Sui Y; Zhang W; Qian L; Wang Z
    Zhonghua Nan Ke Xue; 2004 Aug; 10(8):612-3. PubMed ID: 15362527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Benign prostatic hyperplasia--dos the frequency of operations depend on insurance status?].
    Gass R
    Swiss Surg; 1999; 5(5):233-8. PubMed ID: 10546523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinic analysis of repeat prostatectomy after transurethral prostatectomy for benign prostatic hyperplasia].
    Mao QZ; Rong S; Li HZ; Ji ZG; Xia M; Zang MF
    Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(5):372-4. PubMed ID: 15061986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cost-effectiveness of transurethral resection of the prostate vs thulium laser transurethral vaporesection of the prostate in the UNBLOCS randomised controlled trial for benign prostatic obstruction.
    Noble SM; Ahern AM; Worthington J; Hashim H; Taylor H; Young GJ; Brookes S; Abrams P; Johnson L; Khan R; Page T; Swami KS; Lane JA
    BJU Int; 2020 Nov; 126(5):595-603. PubMed ID: 32558178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinicopathologic patterns of prostatic diseases and prostate cancer in Saudi patients.
    Mosli HA; Abdel-Meguid TA; Al-Maghrabi JA; Kamal WK; Saadah HA; Farsi HM
    Saudi Med J; 2009 Nov; 30(11):1439-43. PubMed ID: 19882057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Open prostatectomy for benign prostatic enlargement in southern Europe in the late 1990s: a contemporary series of 1800 interventions.
    Serretta V; Morgia G; Fondacaro L; Curto G; Lo bianco A; Pirritano D; Melloni D; Orestano F; Motta M; Pavone-Macaluso M;
    Urology; 2002 Oct; 60(4):623-7. PubMed ID: 12385922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Hiraoka's Transurethral Detachment Prostatectomy and Transurethral Resection of the Prostate Effects on Postoperative Erectile Function in Patients With Benign Prostatic Hyperplasia: A Prospective Randomized Controlled Study.
    Pan C; Zhan Y; Zhao Y; Wu B; Bai S
    J Sex Med; 2020 Nov; 17(11):2181-2190. PubMed ID: 32665211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of systematic prostate biopsy on prostate cancer incidence in men with symptomatic benign prostatic hyperplasia undergoing transurethral resection of the prostate.
    Ornstein DK; Rao GS; Smith DS; Andriole GL
    J Urol; 1997 Mar; 157(3):880-3; discussion 883-4. PubMed ID: 9072591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rates of prostate surgery and acute urinary retention for benign prostatic hyperplasia in men treated with dutasteride or finasteride.
    Kuiper JG; Bezemer ID; Driessen MT; Vasylyev A; Roehrborn CG; Penning-van Beest FJ; Herings RM
    BMC Urol; 2016 Aug; 16(1):53. PubMed ID: 27580700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomised controlled trial to determine the clinical and cost effectiveness of thulium laser transurethral vaporesection of the prostate (ThuVARP) versus transurethral resection of the prostate (TURP) in the National Health Service (NHS) - the UNBLOCS trial: a study protocol for a randomised controlled trial.
    Worthington J; Taylor H; Abrams P; Brookes ST; Cotterill N; Noble SM; Page T; Swami KS; Lane JA; Hashim H
    Trials; 2017 Apr; 18(1):179. PubMed ID: 28412960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peri-operative morbidity and changes in symptom scores after transurethral prostatectomy in Switzerland: results of an independent assessment of outcome.
    Müntener M; Aellig S; Küttel R; Gehrlach C; Hauri D; Strebel RT
    BJU Int; 2006 Aug; 98(2):381-3. PubMed ID: 16879681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment Results of Transurethral Resection of the Prostate by Non-Japanese Board-Certified Urologists for Benign Prostate Hyperplasia: Analysis by Resection Volume.
    Suzuki Y; Toyama Y; Nakayama S; Nomura S; Minowa T; Tanabe K; Kondo Y
    J Nippon Med Sch; 2017; 84(2):73-78. PubMed ID: 28502962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Age-related androgen deficiency and benign prostatic hyperplasia: how to improve the rehabilitation of patients after transurethral surgery?].
    Martov AG; Ergakov DV
    Urologiia; 2016 Dec; (6):110-117. PubMed ID: 28248054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Energy delivery systems for treatment of benign prostatic hyperplasia: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(17):1-121. PubMed ID: 23074487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.